RZOLV - BUILDING A CLEAR PATH TO COMMERCIALIZATION...

Transforming Validated Chemistry, Independent Technical Evidence And Field-Scale Operating Experience Into Scalable Licensing, Strategic Partnerships And Commercial Deployment.

ACCOMPLISHMENTS AND EVIDENCE ALREADY GENERATED

 TECHNICAL/SCIENTIFIC ACCOMPLISHMENTS

RZOLV continues to strengthen the scientific and technical foundation of its hydrometallurgical platform. The accomplishments below—including extensive multi-feedstock testing, achievements on complex ores, independent verification, high recoveries, multi-cycle solution reuse, conventional carbon recovery and a 75-tonne field program—provide growing evidence to support larger-scale demonstration, licensing and commercial deployment.

EXTENSIVE METALLURGY TEST DATABASE Thousands of bottle-roll, column, tank and bulk tests across hundreds of ores, concentrates, tailings, and secondary feeds.	LOW TOXICOLOGICAL TEST RESULTS CTRI reported a 57,000-times less toxicity (LC50) than the cited cyanide reference. CTRI independently supported key results.
HIGH GOLD RECOVERIES 99.6% on Alaska gravity residues; independent SGS results of 98.7% on oxide and 89.4% on sulphide concentrates.	75-TONNE BULK FIELD VALIDATION TEST Arizona vat leach test achieved 67.51% Au recovery - (comparable  to CN), stable pH, electrochemically generated ORP, no discharge.
COMPLEX COPPER-GOLD PERFORMANCE 97.0% Au recovery on 2.12% Cu ore; sequential tests recovered 82.3%–94.8% Au and 71%–80% Cu, with 27%–64% lower RZOLV additions after pretreatment.	HIGH SOLUTION RE-USE QUOTIENT Comprehensive locked cycle research averaged more than 94% gold recovery to carbon, with limited deleterious-metal buildup; electrochemical regeneration R&D completed.
CRITICAL MINERAL AND RARE EARTH PLATFORM 89.8% Ag recovery from solar-panel concentrate; plus complexation of more than 32 critical and rare earth elements publicly disclosed.	CONVENTIONAL RECOVERY TO CARBON Activated-carbon loading, stripping and carbon-to-doré demonstrated; integration with existing infrastructure.

CORPORATE & ACADEMIC ACCOMPLISHMENTS

RZOLV continues to strengthen the corporate, academic and commercialization framework supporting its technology platform. Strategic partnerships, government-supported programs, intellectual-property protection, expanded technical capacity, international recognition, public-market access and experienced leadership provide a growing foundation for collaboration, scale-up, licensing and commercial deployment.

STRATEGIC COMMERCIAL RELATIONSHIPS Partnerships and collaborations with EMEW, Aurquest Alaska, Alkemio and other strategic parties.	PROTECTED TECHNOLOGY PLATFORM Patent-pending chemistry, regeneration and processing applications supported by trade-secret protection.
MORE THAN C$10 MILLION INVESTED Capital deployed into chemistry research and development, facilities, personnel, IP patents, testing, scale-up and commercialization.	MORE THAN $450K IN NON-DILUTIVE FUNDING Government grants and financial support  through SR&ED, NRC IRAP, MICA and Global Affairs Canada programs. Multiple grant applications underway in both Canada and the USA.
RECOGNITION AND STOCK MARKET LISTINGS SET100 recognition, CCE -Canadian Clean-Energy Delegation, Global Affairs Canada – India, Japan, Peru, Argentina, NRC/IRAP and CEMI MICA  Delegations.  TSXV listing and subsequent OTCQB and Frankfurt Stock Exchange listings, plus U.S. DTC eligibility.	LEADERSHIP AND TECHNICAL CAPACITY  John McConnell-Victoria Gold, Mary-Ellen Thorburn – Barrick Gold, added to the Board; Dr. Samira Dadsetan, and Wensi Fong, M.Sc. P.Eng added to our science team, new BCIT Campus expansion, and academic studies expanded.

Collectively, these accomplishments demonstrate that RZOLV has advanced well beyond an early-stage laboray concept. Together with private and government-supported research, strategic downstream partnerships and a defined pathway toward sustained pilot and commercial operations, this evidence provides a strong foundation for scale-up, licensing and comtormercial deployment and distinguishes it from a conceptual or pre-validation company and supports its position as an increasingly validated and potentially valuable hydrometallurgical technology platform.

THREE DEVELOPMENT LANES - ONE PLATFORM

RZOLV is not dependent on a single, all-or-nothing commercialization event. The Company is advancing an application-specific platform in which individual opportunities can progress according to their technical readiness, partner participation, capital requirements and shortest credible path to market. We are advancing three complementary/horizontal development pathways:

01. Direct RZOLV Gold Recovery - Conventional oxide heap leaching, concentrates, sulfide and transitional materials, agitated tank and heap/vat leach applications - RZOLV’s initial TAM includes the approximately US$3 billion annual cyanide gold-recovery market, with additional potential where cyanide is constrained by permitting, mineralogy, reagent consumption, environmental requirements or process complexity. Compatibility with existing infrastructure provides an important integration advantage.

02. SEGR: Sequential Low-Ph Copper-Gold And Refractory Platform - Conventional cyanide leaching requires alkaline conditions, so acidic oxidized material must typically be washed and neutralized before gold recovery. RZOLV is designed for low-pH operation. The SEGR architecture connects low pH conditioning or oxidation with staged copper recovery, followed by non-cyanide leaching, downstream recovery and solution regeneration. For refractory feeds, oxidation first exposes the gold; for copper-gold feeds, copper may be recovered as a separate value stream.

03. RZOLV + Alkemio: Critical Minerals And Rare Earth Elements - RZOLV mobilizes rare earth elements; Alkemio selectively separates and upgrades them - Preliminary screening identified responses across light, heavy and magnet rare earths, establishing a basis for integration. Next steps include direct solution analysis, impurity management, selective molecular adsorption separation, product concentration and generation, solution recycling and preliminary economics. This program can advance independently of RZOLV’s gold initiatives. 

 LICENSING:  THE THREAD THAT CONNECTS ALL THREE PATHS.

Our strategy is not dependent on one single, all-or-nothing commercialization event. Each pathway can advance according to its own technical readiness, partner participation and commercial opportunity. RZOLV is building momentum, expanding its strategic relevance and developing an increasingly visible path from proprietary chemistry to commercial deployment.

The Company’s Primary Focus remains the licensing of RZOLV to established cyanide manufacturers and global mining-reagent companies with existing manufacturing and distribution networks and capacity, mine-site relationships, distribution networks and technical-service infrastructure. Rather than requiring RZOLV to independently build a worldwide reagent-production and sales organization, a licensing model could place the technology into the hands of industry participants already capable of supporting customers at commercial scale.

PEER-GROUP CONTEXT:  VALUE CAN BE BUILT BEFORE REVENUE

Pre-revenue does not mean pre-value. Our comprehensive peer-group review of public mineral-processing, separation, recycling, critical-mineral and mine-development companies reinforces an important capital-markets principle: meaningful enterprise value can be created well before commercial revenues.  When a company owns differentiated intellectual property, addresses a strategically important industrial problem, and demonstrates a credible pathway from technical proof to commercial deployment then VALUE has been created.

The market does not value development-stage technology companies solely on their current income statement. It also evaluates the scale and urgency of the opportunity, the defensibility of the technology, the quality and repeatability of technical evidence, the involvement of credible government and industry counterparties.

For RZOLV, those potential value-recognition milestones include continued independent validation on representative feedstocks; conversion of strategic relationships into funded and partner-supported work programs; integrated recovery of saleable metal products; larger pilot or bulk-scale demonstrations; preliminary economics; commercial agreements; initial paid testwork, reagent or licensing revenue; and continued advancement of the Company’s Direct Gold, SEGR and RZOLV–Alkemio development pathways. These are measurable events—not abstract promotional claims.

VALIDATION THROUGH INDUSTRY ASSOCIATION - AND EXECUTION

For an emerging disruptive-technology company, credible industry relationships are important because they place the technology in environments where performance claims must withstand independent scrutiny, practical operating experience and commercial discipline.

Publicly disclosed relationships and funding from government programs include SGS Canada, NRC IRAP, MICA and CEMI, EMEW Clean Technologies and Alkemio Bioscience. These organizations bring validation, technical scrutiny, process capability, industry access, accountability and non-dilutive funding. Additional discussions across global chemical companies, mining companies, engineering companies, equipment providers and strategic capital groups continue, and will be announced subject to confidentiality.

The tangible results of these relationships should produce reduced technical risk, faster validation, stronger market access and a clearer path from promising chemistry to commercial deployment.

ENHANCED INVESTOR-RELATIONS AND MARKET-AWARENESS

RZOLV recognizes that its technical progress and commercialization strategy have not yet reached a sufficiently broad investment audience. The Company is addressing this through expanded investor education, market outreach and communications designed to build a broader, informed and continuously renewed investor base—one that understands the industrial problem RZOLV is solving, the development horizon and the milestones that can reduce risk and create value. These enhanced programs will target retail and institutional investors across Canada, the United States and selected international markets.

THE NEXT PHASE – COMMERCIALIZATION IS THE TARGET...

MILESTONES THAT CAN DRIVE VALUE RECOGNITION

GLOBAL MANUFACTURING & SALES Formal relationships with global chemical and mining-reagent companies for manufacturing and distribution.	PRODUCT LICENSING AND ROYALTIES Licensing agreements structured by territory, commodity, feedstock or field of use, creating scalable reagent-sales, licensing and royalty opportunities.
GOVERNMENT GRANTS & FUNDING Continued funding and support by Canadian and International governments  support global initiatives, strengthen market validation.	COMMERCIAL CLIENT CONVERSION Conversion of prospective customers into paid programs, supply or offtake agreements, product licenses, royalties, toll-treatment arrangements, joint ventures and other revenue-generating relationships.
GLOBAL TECHNOLOGY PARTNERSHIPS Integrated alliances with engineering companies, equipment providers and complementary mining technologies that strengthen the complete flowsheet and accelerate deployment.	PARTNER-BACKED TESTING & PILOTS Integrated campaigns that generate the operating, scale-up, engineering and customer data required to support adoption and commercial decisions.
MINERAL PROJECT PARTNERSHIPS Project-specific relationships with mine owners and developers that can advance into paid test work, pilot campaigns, reagent supply, toll treatment or joint ventures.	CONTINUED TECHNOLOGY DEVELOPMENT Ongoing optimization of metal recovery, impurity control, reagent regeneration, solution recycle, product generation, engineering and preliminary economics. May include strategic acquisitions.

WHAT SHAREHOLDERS SHOULD EXPECT

shareholders should expect a disciplined, milestone-based program focused on converting RZOLV’s technical progress into commercial evidence and defined opportunities. During the next phase, the Company intends to advance global licensing and royalty discussions; continue independent, partner-led and third-party validation of the RZOLV and SEGR platforms; convert strategic relationships into formal work programs, customer testing and pilot campaigns; progress direct-solution recovery and product-generation work through the RZOLV–Alkemio collaboration; establish alliances with complementary mining-technology companies; and expand engagement with retail, institutional and strategic investors.

These initiatives will not necessarily advance at the same pace, but shareholders should expect RZOLV to emphasize measurable execution, transparent reporting and milestones that progressively reduce technical and commercial risk while strengthening the pathway to revenue, licensing and commercial deployment.

OUR COMMITMENT

We believe RZOLV is technically and strategically better positioned today than at any prior point in its development. Confidence must be earned through measurable progress, not slogans. “Our objective has never been simply to prove the chemistry works. Our objective has been to develop a commercially deployable process capable of solving critical metallurgical challenges for the mining industry that unlocks tangible value. We believe we have now reached a stage where our efforts are increasingly focused on commercial applications rather than technical feasibility. “

Thanks for your continued support,

Duane Nelson

President & CEO

---

DISCLAIMER AND FORWARD-LOOKING INFORMATION

This Shareholder Update has been prepared by RZOLV Technologies Inc. (the “Company”) solely to provide shareholders with a general overview of the Company’s technology validation, commercialization activities, strategic relationships and anticipated development milestones. It does not constitute an offer to sell or a solicitation to purchase securities, nor does it constitute investment, financial, legal, tax or technical advice.

This Update contains forward-looking information within the meaning of applicable Canadian securities laws, including statements concerning the continued development, testing, optimization and scale-up of the RZOLV and SEGR platforms; strategic partnerships; licensing, royalty, manufacturing and distribution opportunities; government funding; partner-supported testing and pilot programs; customer conversion; potential revenue; commercial deployment; market opportunities; and milestones that may contribute to value recognition.

Forward-looking information is based on management’s current expectations, estimates and assumptions and is subject to technical, operational, financial, regulatory and commercial risks. Actual results may differ materially due to feedstock-specific mineralogy, differences between laboratory, pilot and commercial-scale performance, reagent consumption, recovery rates, process economics, financing availability, regulatory approvals, intellectual-property risks, competition, market conditions, delays and the decisions of third parties.

There can be no assurance that technical results will be reproduced on other materials or at commercial scale, that proposed programs will be completed, that preliminary discussions or non-binding arrangements will result in definitive agreements, or that any milestone will result in revenue, commercial adoption or an increase in the Company’s share price or valuation.

Market estimates are illustrative and are not forecasts of future sales or profitability. References to third parties do not necessarily imply endorsement or a binding commercial commitment. This Update speaks as of August 4, 2026, and the Company undertakes no obligation to update forward-looking information except as required by applicable law.